1197943-62-6 Usage
Uses
Used in Pharmaceutical Synthesis:
5-Bromo-3-propyl-1H-indazole is used as a building block for the synthesis of various pharmaceuticals and research chemicals. Its unique chemical structure and properties contribute to the development of new drugs with potential therapeutic applications.
Used in Medicinal Chemistry Research:
5-Bromo-3-propyl-1H-indazole is used as a research tool in medicinal chemistry to study its pharmacological effects and explore its potential as a cannabinoid receptor agonist. This helps researchers understand its mechanism of action and its potential role in the development of new therapeutic agents.
Used in Drug Development:
5-Bromo-3-propyl-1H-indazole is used in drug development to evaluate its potential as a lead compound for the treatment of various diseases and conditions. Its activity as a cannabinoid receptor agonist makes it a promising candidate for further research and development in the pharmaceutical industry.
Used in Laboratory Settings:
5-Bromo-3-propyl-1H-indazole is primarily used in laboratory settings for experimental purposes. Researchers utilize this compound to conduct various experiments and studies to better understand its properties, potential applications, and effects on biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 1197943-62-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,7,9,4 and 3 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1197943-62:
(9*1)+(8*1)+(7*9)+(6*7)+(5*9)+(4*4)+(3*3)+(2*6)+(1*2)=206
206 % 10 = 6
So 1197943-62-6 is a valid CAS Registry Number.
1197943-62-6Relevant articles and documents
EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF
-
Paragraph 0106; 0611; 0612, (2017/09/02)
A 4-substituted-2-(N-(5-substituted allyl amide)phenyl)amino)pyrimidine derivative as represented by formula (I), and a preparation and application thereof as an EGFR inhibitor. The compound has activity of inhibiting the L858R EGFR mutant, the T790M EGFR mutant and the exon 19 deletion activating mutant, may be used to treat diseases mediated alone or in part by EGFR mutant activity, and has a wide application in drugs preventing and treating cancers, particularly non-small cell lung cancer.
PYRAZOLOSPIROKETONE ACETYL-C0A CARBOXYLASE INHIBITORS
-
Page/Page column 44-45, (2009/12/27)
The invention provides compounds of Formula (1) or a pharmaceutically acceptable salt of said compound, wherein R1, R2, and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of acetyl-CoA carboxylase enzyme(s) in an animal.